Results 81 to 90 of about 5,952 (213)

R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma

eLife, 2019
Propranolol is an approved non-selective β-adrenergic blocker that is first line therapy for infantile hemangioma. Despite the clinical benefit of propranolol therapy in hemangioma, the mechanistic understanding of what drives this outcome is limited ...
Jeroen Overman, Frank Fontaine, Jill Wylie-Sears, Mehdi Moustaqil, Lan Huang, Marie Meurer, Ivy Kim Chiang, Emmanuelle Lesieur, Jatin Patel, Johannes Zuegg, Eddy Pasquier, Emma Sierecki, Yann Gambin, Mohamed Hamdan, Kiarash Khosrotehrani, Gregor Andelfinger, Joyce Bischoff, Mathias Francois   +17 more
doaj   +1 more source

An interesting case of genital infantile hemangioma

, 2023
Vascular lesions are commonly seen in newborns. They may be present at birth or appear in the days, weeks or months that follow. Most are benign and self-limiting but rarely they may be part of complex syndromes or systemic disorders, or they may be ...
Mahmood, Shafqat, Naeem, Muhammad
core   +1 more source

Experience with the successful use of topical beta-adrenoblockers in the treatment of infantile hemangiomas: a clinical case and review of the literature

Лечащий Врач
Background. Infantile (infantile) hemangiomas are benign vascular tumors found predominantly in the pediatric population. Its presence can lead not only to aesthetic discomfort of the child, but also to gross functional disorders.
R. V. Saranyuk, T. A. Gosteva
doaj   +1 more source

Propranolol Treatment in the Management of Infantile Hemangioma in Erbil, Iraq [PDF]

Iranian Journal of Neonatology
Background: Infantile hemangioma is a common benign vascular tumor that affects up to 10% of infants. Propranolol, a beta-blocker, has been used as a promising treatment for infantile hemangioma, but its effectiveness remains controversial.
Wesam Boya Kaka, Siamand Salim, Jalal Fattah   +2 more
doaj   +1 more source

Propranolol and Neurodevelopment in Infantile Hemangioma: Reassuring Signals From Real‐World Data

JEADV Clinical Practice, Volume 5, Issue 2, Page 363-364, June 2026.
Alain Taïeb
wiley   +1 more source

Cellular Targets of Propranolol in Infantile Hemangioma [PDF]

, 2015
Infantile hemangioma (IH) is a vascular neoplasm that affects 4-10 percent of infants. Propranolol, a non-selective beta-adrenergic receptor (AR) antagonist, was serendipitously discovered to accelerate regression of IH in 2008; however, its mechanism ...
Lee, D.
core  

Spontaneous resolution of an infantile hemangioma in a dorsal root ganglion

, 2011
Infantile hemangiomas are tumors commonly seen in children. Few authors have reported infantile hemangiomas affecting the CNS, and there are no prior reports detailing spontaneous resolution of a histologically proven juvenile hemangioma within a dorsal ...
Shawn L. Hervey-Jumper, Cormac O. Maher, Karin M. Muraszko, Paul E. McKeever, Stephen S. Gebarski   +4 more
core   +1 more source

Oral propranolol therapy in 23 infants with infantile hemangioma [PDF]

, 2018
Background Infantile hemangioma (IH) is a common vascular tumor in pediatric patients, and is commonly treated with propranolol. We describe our experiences with dosage, response to treatment, and side effects in 23 IH patients treated with ...
Tai Suk Roh, Jong Won Hong, Jaeyoon Kim, Won Jai Lee   +3 more
core   +1 more source

Editor's Picks June 2026

JEADV Clinical Practice, Volume 5, Issue 2, Page 357-360, June 2026.
Antonio Torrelo
wiley   +1 more source

Vaginal Bleeding Due to an Infantile Hemangioma in a 3-Year-Old Girl

, 2009
Infantile hemangiomas may cause vaginal bleeding in prepubescent girls. A 3-year-old girl was referred for evaluation of painless vaginal bleeding. Her initial evaluation was nondiagnostic.
Roscoe, Jill, Sims, Shireen Madani, Jackson, M. Gerard, Davis, John D., Ross, Helen, Simms-Cendan, Judith, McLean, Frederick W.   +6 more
core   +1 more source